I agree that this site is using cookies. You can find further informations here.
X
Morimoto, Yoshie
136  results:
Search for persons X
?
1

Safety of First-Line Nivolumab Plus Ipilimumab in Very Old ..:

Shimamoto, Takayuki ; Morimoto, Yoshie ; Nitta, Naohiro..
Cureus.  , 2024
Link: https://doi.org/10.7759/..
 
?
2

Durable Response to Chemoimmunotherapy of a Lung Adenocarci..:

Nitta, Naohiro ; Morimoto, Yoshie ; Tani, Nozomi.
Cureus.  , 2023
Link: https://doi.org/10.7759/..
 
?
3

Osimertinib and Bevacizumab Cotreatment for Untreated EGFR-..:

Hibino, Makoto ; Hiranuma, Osamu ; Takemura, Yoshizumi...
JTO Clinical and Research Reports.  3 (2022)  12 - p. 100424 , 2022
Link: https://doi.org/10.1016/..
 
?
4

A Real-World Analysis of Immune Checkpoint Inhibitor-Based ..:

Morimoto, Kenji ; Sawada, Ryo ; Yamada, Tadaaki...
JTO Clinical and Research Reports.  3 (2022)  9 - p. 100388 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Efficacy and Safety of Programmed Death-Ligand 1 Inhibitor ..:

Morimoto, Kenji ; Yamada, Tadaaki ; Takeda, Takayuki...
JTO Clinical and Research Reports.  3 (2022)  7 - p. 100353 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Heterogeneity among tumors with acquired resistance to EGFR..:

Katayama, Yuki ; Yamada, Tadaaki ; Tokuda, Shinsaku...
Cancer Medicine.  11 (2022)  4 - p. 944-955 , 2022
Link: https://doi.org/10.1002/..
 
?
7

Corrigendum to "A real-world study on the safety of the ext..:

Morimoto, Kenji ; Yamada, Tadaaki ; Morimoto, Yoshie...
International Immunopharmacology.  112 (2022)  - p. 109232 , 2022
Link: https://doi.org/10.1016/..
 
?
8

HER3 activation contributes toward the emergence of ALK inh..:

Tanimura, Keiko ; Yamada, Tadaaki ; Okada, Koutaroh...
npj Precision Oncology.  6 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
9

A real-world study on the safety of the extended dosing sch..:

Morimoto, Kenji ; Yamada, Tadaaki ; Morimoto, Yoshie...
International Immunopharmacology.  108 (2022)  - p. 108775 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Prognostic Nutritional Index and Lung Immune Prognostic Ind..:

Tanaka, Satomi ; Uchino, Junji ; Yokoi, Takashi...
Diagnostics.  12 (2022)  2 - p. 423 , 2022
Link: https://doi.org/10.3390/..
 
?
11

Concurrent hemoptysis and pulmonary embolism associated wit..:

Fujii, Hiroyuki ; Iwasaku, Masahiro ; Kuno, Haruka...
Current Problems in Cancer: Case Reports.  6 (2022)  - p. 100164 , 2022
Link: https://doi.org/10.1016/..
 
?
12

The Impact of VEGF Inhibition on Clinical Outcomes in Patie..:

Tanimura, Keiko ; Yamada, Tadaaki ; Omura, Ayaka...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
13

Early discontinuation of induction therapy in chemoimmunoth..:

Morimoto, Kenji ; Uchino, Junji ; Yokoi, Takashi...
Journal of Cancer Research and Clinical Oncology.  148 (2021)  9 - p. 2437-2446 , 2021
Link: https://doi.org/10.1007/..
 
?
14

Impact of maintenance therapy following induction immunoche..:

Nakamura, Ryota ; Yamada, Tadaaki ; Morimoto, Kenji...
Journal of Cancer Research and Clinical Oncology.  148 (2021)  11 - p. 2985-2994 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Inhibition of c-Jun N-terminal kinase signaling increased a..:

Tanimura, Keiko ; Yamada, Tadaaki ; Horinaka, Mano...
Cancer Letters.  522 (2021)  - p. 119-128 , 2021
Link: https://doi.org/10.1016/..
 
1-15